Richard A. Larson to Evaluation Studies as Topic
This is a "connection" page, showing publications Richard A. Larson has written about Evaluation Studies as Topic.
Connection Strength
0.098
-
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer. 2005 Oct 01; 104(7):1442-52.
Score: 0.064
-
Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood. 1996 Oct 01; 88(7):2665-70.
Score: 0.034